Update on Management of Clostridium difficile Infection

作者: Camille Beauduy , Conan MacDougall

DOI: 10.1310/HPJ4802-S7

关键词:

摘要: Clostridium difficile infection (CDI) is a major cause of morbidity and mortality, both in hospitalized patients the community. Despite importance CDI, therapeutic options remain limited. The Society for Hospital Epidemiology America Infectious Diseases published guidelines CDI management 2010. Recommendations based on randomized controlled trial data include metronidazole or oral vancomycin mild to moderate disease severe disease. Since publication these guidelines, fidaxomicin has been approved trials showing similar clinical cure rates lower recurrence rate compared vancomycin. Patients with fulminant, complicated, multiply recurrent have not included trials, so decisions are supported by observational anecdotal studies. Epidemiologic studies consistently identify systemic antibiotic use as risk factor development CDI. This tends in...

参考文章(42)
P. R. Ingram, J. M. Seet, C. A. Budgeon, R. Murray, Point‐prevalence study of inappropriate antibiotic use at a tertiary Australian hospital Internal Medicine Journal. ,vol. 42, pp. 719- 721 ,(2012) , 10.1111/J.1445-5994.2012.02809.X
Sahil Khanna, Darrell S Pardi, Scott L Aronson, Patricia P Kammer, Robert Orenstein, Jennifer L St Sauver, Scott W Harmsen, Alan R Zinsmeister, The epidemiology of community-acquired Clostridium difficile infection: a population-based study The American Journal of Gastroenterology. ,vol. 107, pp. 89- 95 ,(2012) , 10.1038/AJG.2011.398
Spencer E. Harpe, Timothy J. Inocencio, Amy L. Pakyz, Michael J. Oinonen, Ronald E. Polk, Characterization of Continued Antibacterial Therapy After Diagnosis of Hospital-Onset Clostridium difficile Infection: Implications for Antimicrobial Stewardship Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. ,vol. 32, pp. 744- 754 ,(2012) , 10.1002/J.1875-9114.2012.01160.X
Philip Carling, Teresa Fung, Ann Killion, Norma Terrin, Michael Barza, Favorable impact of A multidisciplinary antibiotic management program conducted during 7 years Infection Control and Hospital Epidemiology. ,vol. 24, pp. 699- 706 ,(2003) , 10.1086/502278
Marion Elligsen, Sandra AN Walker, Ruxandra Pinto, Andrew Simor, Samira Mubareka, Anita Rachlis, Vanessa Allen, Nick Daneman, None, Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis. Infection Control and Hospital Epidemiology. ,vol. 33, pp. 354- 361 ,(2012) , 10.1086/664757
Stuart McPherson, Colin J. Rees, Richard Ellis, Shelly Soo, Simon J. Panter, Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Diseases of The Colon & Rectum. ,vol. 49, pp. 640- 645 ,(2006) , 10.1007/S10350-006-0511-8
Valerie Leung, Suzanne Gill, Jaclyn Sauve, Kelly Walker, Carmine Stumpo, Jeff Powis, Growing a “Positive Culture” of Antimicrobial Stewardship in a Community Hospital The Canadian Journal of Hospital Pharmacy. ,vol. 64, pp. 314- ,(2011) , 10.4212/CJHP.V64I5.1065
Michael A. Nowak, Robert E. Nelson, Jesse L. Breidenbach, Paul A. Thompson, Paul J. Carson, Clinical and economic outcomes of a prospective antimicrobial stewardship program American Journal of Health-system Pharmacy. ,vol. 69, pp. 1500- 1508 ,(2012) , 10.2146/AJHP110603
Scott Modena MD, Satya Gollamudi, Frank Friedenberg, Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea. Journal of Clinical Gastroenterology. ,vol. 40, pp. 49- 54 ,(2006) , 10.1097/01.MCG.0000190761.80615.0F
Charles Venuto, Mary Butler, Elizabeth Dodds Ashley, Jack Brown, Alternative therapies for Clostridium difficile infections. Pharmacotherapy. ,vol. 30, pp. 1266- 1278 ,(2010) , 10.1592/PHCO.30.12.1266